Ikibazo gihuza ibibazo · Hagati Urwego

HHS Igice cya 1557 Amategeko yerekeye Ikibazo cya Algorithms Ikibazo

Subiramo Igice cya 1557 amategeko yubuvuzi-ibikoresho, ibigo bikubiyemo, imbaraga zifatika, hamwe nuburyo bwo kubahiriza ubufasha bwo kwita.

Ikibazo 1 Bya 8

Ni ubuhe buryo bw'amategeko bukemura ibikoresho byo gufata neza abarwayi?

Reba buri kibazo8 ibibazo

Ibisubizo nibisobanuro bigaragara mugihe ufata ikibazo.

  1. Ni ubuhe buryo bw'amategeko bukemura ibikoresho byo gufata neza abarwayi?
    • 45 CFR 92.210
    • 45 CFR 92.101 only
    • 21 CFR 807.87
    • 42 CFR 1002.9
  2. Nibihe bikoresho bikubiye mu gice cya 92.210?
    • Only a deep learning model
    • Only a device cleared by FDA
    • An automated or non-automated tool supporting clinical decision-making
    • Only software that makes final decisions
  3. Ni ibiki bigomba gutwikirwa bigomba gushyiraho ingamba zifatika zo gukora?
    • Publish every training record
    • Identify tools using protected-characteristic factors and mitigate discrimination risk
    • Ban all use of prediction tools
    • Obtain FDA approval for every model
  4. Did HHS say its June 2026 partial vacatur eliminated §92.210?
    • Yes, it repealed every Section 1557 rule
    • Yes, it ended all civil-rights enforcement
    • No, the notice only concerned FDA devices
    • No; the notice described vacatur of specified gender-identity provisions
  5. §92.210 ikoreshwa mubikoresho byikora gusa?
    • Yes, only neural networks
    • Yes, only products with FDA clearance
    • No; it includes non-automated tools that support clinical decisions
    • No, it applies to every hospital process
  6. Does the rule require notifying each patient about the training data of every tool?
    • No; HHS declined to add that specific notification requirement
    • Yes, for every score
    • Only for FDA devices
    • Yes, but only if the tool is proprietary
  7. What should a covered entity assess about a tool?
    • Only the vendor’s name
    • Only the average accuracy
    • Only its price
    • Its intended use, population, inputs, impact, and mitigation needs
  8. Which step helps a covered entity begin compliance?
    • Wait for a complaint before reviewing
    • Inventory relevant tools and document reasonable review steps
    • Assume a vendor handles all duties
    • Delete all model records